Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masatomo Taniguchi

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Clinical Calcium|January 8, 2008
[Basic and clinical aspects of calcimimetics. Beneficial and adverse effects of calcimimetics on various organs]Masatomo Taniguchi
Clinical Calcium|June 30, 2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality]Masatomo Taniguchi
Clinical Calcium|February 3, 2009
[Use of phosphate binder in predialysis patients]Masatomo Taniguchi
Clinical Calcium|November 27, 2014
[New Developments in CKD-MBD. The present state and problem of CKD-MBD treatment in Japan]Masatomo Taniguchi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2007
Can calcimimetics inhibit nodular hyperplasia of parathyroid glands?Masafumi Fukagawa, Masatomo Taniguchi
Clinical Calcium|May 2, 2007
[The mechanisms of parathyroid hyperplasia and its regression]Masanori Tokumoto, Masatomo Taniguchi
Clinical Calcium|July 4, 2012
[Kidney and bone update : the 5-year history and future of CKD-MBD. Disorders of musculoskeletal system in CKD ; bone fracture and periarticular calcification]Shunsuke Yamada, Masatomo Taniguchi
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|August 26, 2003
[Cell cycle progression in secondary hyperparathyroidism]Masanori Tokumoto, Masatomo Taniguchi, Hideki Hirakata
Kidney International Supplements|July 15, 2014
A Japanese approach for CKD-MBDKeitaro Yokoyama, Masatomo Taniguchi, Masafumi Fukagawa
Nephrology (Carlton, Vic.)|July 1, 2009
Recurrent sarcoidosis with psoas muscle granuloma and hypercalcaemia in a patient on chronic haemodialysisShunsuke Yamada, Masatomo Taniguchi, Kazuhiko Tsuruya, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Clinical Calcium|January 8, 2008
[Basic and clinical aspects of calcimimetics. Beneficial and adverse effects of calcimimetics on various organs]Masatomo Taniguchi
Clinical Calcium|June 30, 2010
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). The impact of CKD-MBD on mortality]Masatomo Taniguchi
Clinical Calcium|February 3, 2009
[Use of phosphate binder in predialysis patients]Masatomo Taniguchi
Clinical Calcium|November 27, 2014
[New Developments in CKD-MBD. The present state and problem of CKD-MBD treatment in Japan]Masatomo Taniguchi
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2007
Can calcimimetics inhibit nodular hyperplasia of parathyroid glands?Masafumi Fukagawa, Masatomo Taniguchi
Clinical Calcium|May 2, 2007
[The mechanisms of parathyroid hyperplasia and its regression]Masanori Tokumoto, Masatomo Taniguchi
Clinical Calcium|July 4, 2012
[Kidney and bone update : the 5-year history and future of CKD-MBD. Disorders of musculoskeletal system in CKD ; bone fracture and periarticular calcification]Shunsuke Yamada, Masatomo Taniguchi
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|August 26, 2003
[Cell cycle progression in secondary hyperparathyroidism]Masanori Tokumoto, Masatomo Taniguchi, Hideki Hirakata
Kidney International Supplements|July 15, 2014
A Japanese approach for CKD-MBDKeitaro Yokoyama, Masatomo Taniguchi, Masafumi Fukagawa
Nephrology (Carlton, Vic.)|July 1, 2009
Recurrent sarcoidosis with psoas muscle granuloma and hypercalcaemia in a patient on chronic haemodialysisShunsuke Yamada, Masatomo Taniguchi, Kazuhiko Tsuruya, et al.
Pageof 12